请输入关键字
请输入关键字
订购
*国家
中国
美国
*省份
*城市
*姓名
*电话
*单位
*职位
*邮箱
*请输入验证码
*验证码
B-hCCR8 mice
Strain Name C57BL/6-Ccr8tm1(CCR8)/Bcgen Common Name  B-hCCR8 mice
Background C57BL/6 Catalog number  110096
Related Genes 
C-C motif chemokine receptor 8; CY6; TER1; CCR-8; CKRL1; CDw198; CMKBR8; GPRCY6; CMKBRL2; CC-CKR-8

Gene description


CCR8 is a chemokine receptor that belongs to the β chemokine receptor family,  the single crystal structure has not been deciphered, but is predicted to be a seven-transmembrane protein, similar to G-protein-coupled receptors. CCR8 expression is low or absent in Treg of normal tissues (e.g.thymus, spleen) and peripheral blood, predominantly highly expressed in tumor-infiltrating Treg. Chemokines and their receptors are important for the migration of various cell types into the inflammatory sites. In human peripheral blood cells, over 30% of Treg upregulate CCR8 in response to CCL1. This interaction induces stat3-dependent upregulation of FOXp3, CD39, IL-10, and granzyme B, which enhances the immunosuppressive activity of these Treg cells. There are currently four known human CCR8 ligands, CCL1, CCL8, CCL16, and CCL18, of which CCR8 is a specific receptor for CCL1, which has a more significant role in enhancing Treg cell immunosuppression.CCR8 may be an effective therapeutic target by which to selectively and specifically modulate a subpopulation of tumor-resident Tregs in the TME to augment antitumor immunity. CCR8 may be a promising new target for cancer immunotherapy and its potential for broad clinical application. 


mRNA expression analysis


from clipboard


Strain specific analysis of CCR8 gene expression in C57BL/6 and B-hCCR8 mice by RT-PCR. Mouse Ccr8 mRNA was detectable in thymocytes of wild-type mice (+/+) . Human CCR8 mRNA was detectable only in homozygous B-hCCR8 mice (H/H) but not in wild-type mice (+/+). 


Protein expression analysis


from clipboard


Strain specific analysis of CCR8 gene expression in B-hCCR8 mice by FACS. MC38 cells were inoculated into wild-type C57BL/6 (+/+) and homozygous B-hCCR8 mice (H/H). Tumors were harvested at the endpoint of experiment, and the TILs were analyzed by flow cytometry. Human CCR8 was both detectable on CD4+ T cells and Tregs in tumors of homozygous B-hCCR8 mice, and mouse CCR8 was detectable only in Wild-type mice.


Analysis of leukocytes cell subpopulation in B-hCCR8 mice

from clipboard


from clipboard


Analysis of spleen leukocyte subpopulations by FACS. Splenocytes were isolated from female C57BL/6 and B-hCCR8 mice (n=3, 8-week-old). Flow cytometry analysis of the splenocytes were performed to assess leukocyte subpopulations. A. Representative FACS plots. Single live cells were gated for the CD45+ population and used for further analysis as indicated here. B. Results of FACS analysis. Percent of T cell, B cell, NK cell, monocyte, dendritic cell, granulocyte and macrophage in homozygous B-hCCR8 mice were similar to those in the C57BL/6 mice, demonstrating that CCR8 humanized does not change the overall development, differentiation or distribution of these cell types in spleen. Values are expressed as mean ± SEM.

Analysis of leukocytes cell subpopulation in B-hCCR8 mice

from clipboard

from clipboard


Analysis of thymus leukocyte subpopulations by FACS. Thymocytes were isolated from female C57BL/6 and B-hCCR8 mice (n=3, 8-week-old). Flow cytometry analysis of the thymocytes were performed to assess leukocyte subpopulations. A. Representative FACS plots. Single live cells were gated for the CD45+ population and used for further analysis as indicated here. B. Results of FACS analysis. Percent of T cell, B cell, NK cell, monocyte, dendritic cell, granulocyte and macrophage in homozygous B-hCCR8 mice were similar to those in the C57BL/6 mice, demonstrating that CCR8 humanized does not change the overall development, differentiation or distribution of these cell types in thymus. Values are expressed as mean ± SEM.

Analysis of leukocytes cell subpopulation in B-hCCR8 mice

from clipboard

from clipboard


Analysis of blood leukocyte subpopulations by FACS. Blood were isolated from female C57BL/6 and B-hCCR8 mice (n=3, 8-week-old). Flow cytometry analysis of the blood were performed to assess leukocyte subpopulations. A. Representative FACS plots. Single live cells were gated for the CD45+ population and used for further analysis as indicated here. B. Results of FACS analysis. Percent of T cell, B cell, NK cell, monocyte, dendritic cell, granulocyte and macrophage in homozygous B-hCCR8 mice were similar to those in the C57BL/6 mice, demonstrating that CCR8 humanized does not change the overall development, differentiation or distribution of these cell types in blood. Values are expressed as mean ± SEM.


Analysis of leukocytes cell subpopulation in B-hCCR8  mice


from clipboard

from clipboard


Analysis of T cell subpopulation in spleen, thymus and blood.

The lymphocytes were isolated from spleen, thymus and blood in C57BL/6 and B-hCCR8 mice (n=3, 8-week-old). The proportion of T cells subpopulation was tested by flow cytometry. There were no differences between C57BL/6 and B-hCCR8 mice, demonstrating that humanized of CCR8 does not change the overall development, differentiation or distribution of these T cell subtypes. Values are expressed as mean ± SEM (please confirm)


In vivo efficacy of anti-human CCR8 antibody


from clipboard

Antitumor activity of anti-human CCR8 antibody in B-hCCR8 mice. (A) Anti-human CCR8 antibody get from cooperation company inhibited MC38 tumor growth in B-hCCR8 mice. Murine colon cancer MC38 cells were subcutaneously implanted into homozygous B-hCCR8 mice (female, 8 week-old, n=7). Mice were grouped when tumor volume reached approximately 100 mm3, at which time they were treated with anti-human CCR8 antibody. (B) Body weight changes during treatment. As shown in panel A, anti-human CCR8 antibody were efficacious in controlling tumor growth in B-hCCR8 mice. B-hCCR8 mice provide a powerful preclinical model for in vivo evaluation of anti-human CCR8 antibody. Values are expressed as mean ± SEM.